FDA Approves Unknown Drug — CELLTRION INC
On January 24, 2025, CELLTRION INC received FDA approval for the new product, a development that underscores the company's strong pipeline and is expected to drive significant market expansion and stock momentum in the specialized sector.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed